This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The patient-focused report gets specific about people dealing with asthma, COPD, Type 2 diabetes, heart disease, psoriasis, and atopic dermatitis with a lens on what bio-pharmaceutical manufacturers (biopharma) can do to better support people in managing these conditions.
–(BUSINESS WIRE)–Aptar DigitalHealth, a global leader in digitalhealth solutions enhancing the patientexperience, today announces the positive results from the SPEED 1 survey, showcasing the impact of the iPUMP connected assistant on adherence to Stallergenes Greers sublingual liquid immunotherapy (SLIT).
When announced, the news was a signal that health care and the larger tech-enabled ecosystem that supports health and well-being is embedded in peoples’ everyday lives. We can expect to see more women-related health tech featured at CES 2022, including on education panels and speaking platforms.
Aptar DigitalHealth’s SaMD platform offers digitalhealth solutions adapted to the patient’s profile, disease state and treatment plan to empower them during their treatment journey. CRYSTAL LAKE, Ill.–(BUSINESS
There’s a gap between the supply of digitalhealth tools that hospitals and health systems offer patients, and what patients-as-consumers need for overall health and wellbeing. Nowhere in the top 10 most commonly provided digital tools is one for price transparency, cost comparing or cost estimating. .
This news is a signal that health care and the larger tech-enabled ecosystem that supports health and well-being is embedded in peoples’ everyday lives. We can expect to see more women-related health tech featured at CES 2022, including on education panels and speaking platforms.
Trust has become a key currency in provider/patient/supplier relationships: 94% of health executives say treating customers as partners is important to gain trust, according to the DigitalHealth Tech Vision 2018 from Accenture. Accenture’s vision this year is built on five pillars: Citizen AI. Extended Reality.
The joint agreement marks a key step in tackling rising drug costs and improving patient access globally. By combining AI-driven insights with robust data, payers and pharmaceutical companies can reduce inefficiencies and ensure patients receive timely access to life-saving therapies.
The acquisition of Healint aligns with Aptar DigitalHealth’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digitalhealth deployment. CRYSTAL LAKE, Ill.–(BUSINESS
Most notably, I call out Ian Morrison who led Institute for the Future (and the health care practice at IFTF) for many years, ten of which I was affiliated with the Institute. I was lucky to collaborate with several of the smartest Yoda-practitioners in scenario planning.
The companys integrated solutions are rooted in the patientexperience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers.
This capability is attracting pharmaceutical and life science companies, health care providers and research organizations to take a closer look at Seqster’s offering. Takeda is one of the organizations that has implemented Seqster’s solution, leveraging real-time data for research and patient services.
The companys integrated solutions are rooted in the patientexperience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers.
The report found three big shifts in global health citizens’ views on their personal health and health care delivery in the wake of the pandemic: Across all age groups, COVID-19 exacerbated peoples’ concerns about their physical and mental health in a very short time.
Benefiting from the combined capabilities and digital platforms of both organizations, the partnership will provide integrated solutions to pharmaceutical partners aiming to enhance patientexperiences. We are pleased to collaborate with Iona Mind, and to offer accessible mental health support to more patients.”
Other potential topics: Health equity and social determinants of health. The patientexperience and consumer-centric healthcare. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, DigitalHealth Insights and Analysis. Subscribe Today!
Together, the organizations will seek to harness the power of generative AI to help pharmaceutical and life science manufacturers drive efficiencies and business value while improving patient outcomes.
Six in 10 patients said their trust/believe in health care providers increased as a result of COVID-19, followed by 50% of patients finding increased trust in urgent care clinics, 49% in public health institutions, 48% in independent pharmacies. 45% in pharmaceutical companies, and 44% in large retail pharmacy chains.
We expect at least 2,400 attendees registered for the meeting, and they’ll not just be representing the health insurance industry itself; folks will attend #AHIP2024 from other industry segments including pharmaceuticals, technology, hospitals and health systems, and the investment and financial services communities.
–(BUSINESS WIRE)–Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. NYSE and TASE: TEVA), today announced that a respiratory patient monitoring program using data from Teva’s Digihaler System has been implemented within California’s Desert Oasis Healthcare (DOHC) system.
.” I’ve bold-faced the last phrase here because it speaks to empathy and the human touch people are seeking — as they continue to undergo their own personal brands of digital transformation — such as using apps for health management, like refilling prescriptions.
Each year, ECRI (the ECRI Institute) publishes an annual report on the Top 10 Patient Safety Concerns for the year. The 2025 list was published today. My read of it is that most of these risks have to do with what I’ve been referring to as the Human OS, the Human Operating System, in my talks and teachings.
NEW YORK–(BUSINESS WIRE)– CI&T (NYSE:CINT), a leader in driving AI-powered digital transformation for global brands, will be showcasing its innovative solutions to advance the future of healthcare and life sciences at the 2024 HIMSS Global Health Conference taking place in Orlando, FL on March 11-15, 2024.
Cabinet Health Rx tackles the pharmaceutical plastic crisis with new digitalhealth platform and sustainable packaging NEW YORK–(BUSINESS WIRE)– Cabinet Health launched its refillable mail-order prescription solution. The business was founded to eradicate waste from the $1.2
Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, DigitalHealth Insights and Analysis. This involves considering factors such as affordability, accessibility, quality of care, and patientexperience. Subscribe Today! Subscribe Today!
This collaboration aims to propel the development of tailored medical treatments by leveraging Closed Loop Medicine’s cutting-edge software as a medical device (SaMD) technology platform, alongside Teva UK’s pharmaceutical expertise. Being able to predict personalized dose levels could be transformational.
.–(BUSINESS WIRE)–AmerisourceBergen (AB), a global healthcare company, has announced a strategic partnership with SteadyMD, a B2B telehealth infrastructure provider that powers high-quality telehealth patientexperiences for leaders and innovators in healthcare.
BERLIN – October 7, 2024 – EVERSANA , a leading provider of global commercial services to the life sciences industry, today announced the continued growth of its European footprint with a new office in Berlin, Germany, Europe’s largest pharmaceutical market.
–(BUSINESS WIRE)–Blue Heron Capital, an early-stage growth equity firm, is excited to announce its investment in Redi Health, a digitalhealth innovator poised to transform patient support services. RICHMOND, Va.–(BUSINESS
Combined, the network helps pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, and solve unique geographic and market-specific challenges. They are, however, fully owned and operated by EVERSANA.
And the healthcare giant, which has developed or acquired its way to market dominance, now has the ability to guide patients to their preferred providers, treatments and services. Not only does it ignore the way people use technology, it puts the patientexperience second. But “one app to rule them all” is flawed. Here’s why.
This isn’t just a recommendation for health care providers, insurance plans, and pharmaceutical and med-tech companies. .” My takeaway here in the Hot Points for the AARP report is RTI’s assertion that dignity is a table stake for delivering high-quality healthcare to seniors.
The collaboration seeks to better equip clinicians with technology to precisely diagnose and treat medical conditions and personalize the patientexperience at each step of their care journey through the clinical translation of novel technologies and approaches to medical imaging and theranostics. “We We are an $18.3
Combination of AI-enabled clinical trial matching, genetic testing, symptom management, psychosocial, and lifestyle support addresses physical and mental health gaps patientsexperience in seeking and accessing treatments while accelerating access to these critical resources.
Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. However, we are still missing the mark with patient involvement to make durable healthcare change towards a culture of patient centricity.
Note the book cover’s digitalhealth-tech personae of some of the myriad characters imagined in Bosch’s canvas. See Adam wearing Google glasses and Eve next to a digital twin, health devices, remote health tech and skin-worn sensors.
Furthermore, nearly 3 in 5 consumers with less than $35,000/yr believe digitalhealth tools can help with diet and activity, an opportunity to engage people say on Medicaid to adopt digital therapeutics and wearable tech for mindful management of activity and medication adherence, as examples.
Its ability to synchronise monitoring of patients at home or at local clinics and to provide diagnostic, treatment and clinical trials intelligence can be transformative. It stated: ‘By 2025, global spend on digitalhealth is predicted to reach €1tn and digital products and services will grow to a market share of 12% (Choueiri et al.,
The American Medical Association and Manatt Health released a blueprint for digitalhealth to help health systems achieve optimized digitally enabled care and bridge the digital divide. Teva Pharmaceuticals is partnering with Healthsnap and Rimidi to increase patient access to the Digihaler system.
In health care, one of the “gifts” inspired by the coronavirus pandemic was the industry’s fast-pivot and adoption of digitalhealth tools — especially telehealth and more generally the so-called “digital front doors” enabling patients to access medical services and personal work-flows for their care.
” These ratings cover over 2,100 pharmaceutical brands for which over 40,000 having submitted opinions. 80% trust recommendations of doctors with real world experience with a drug, and. 84% believe Drug Ratings will lead to better patient outcomes.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content